| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$196 |
1H FY26 Results Presentation
|
27 Feb 2026 8:15AM |
$0.185 |
$0.175 |
fallen by
5.41%
|
|
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$1,554 |
Birketu Change in substantial holding and equity swaps
|
27 Feb 2026 8:15AM |
$1.060 |
$0.980 |
fallen by
7.55%
|
|
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$196 |
1H FY26 Results
|
27 Feb 2026 8:15AM |
$0.185 |
$0.175 |
fallen by
5.41%
|
|
BET - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 13.8% to $46.1 million compared to 1H FY25.
- Adjusted EBITDA improved to $6.0 million from a loss of $1.3 million in 1H FY25.
- Gross Margin expanded to 66.5% from 59.7% in the prior period.
- BetMakers entered a 5-year technology agreement with CrownBet.
- Signed a multi-year agreement with Stake.com for global horse racing expansion.
- Completed acquisition of Las Vegas Dissemination Company (LVDC), contributing $4.5 million in annual revenue.
- Operating costs reduced to $54.3 million.
- The company is focusing on monetizing new contracts and margin improvement.
- BetMakers is advancing digital tote products in Nevada.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atturra Limited (ATA) ORDINARY FULLY PAID |
Information Technology |
$166 |
Update - Notification of buy-back - ATA
|
27 Feb 2026 8:15AM |
$0.585 |
$0.450 |
fallen by
23.08%
|
|
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$196 |
Half Year Report and Appendix 4D
|
27 Feb 2026 8:14AM |
$0.185 |
$0.175 |
fallen by
5.41%
|
|
BET - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues increased by 11.4% to $46.1 million.
- Net loss after tax improved to $3.4 million from $17.2 million.
- Gross margin increased by 19%.
- No dividends were declared.
- Adjusted EBITDA improved significantly.
- Completed acquisition of Las Vegas Dissemination Company.
- Global Betting Services division entered a scalable growth phase.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$68 |
Update - Notification of buy-back - BOL
|
27 Feb 2026 8:14AM |
$1.880 |
$1.775 |
fallen by
5.59%
|
|
| DXN Limited (DXN) ORDINARY FULLY PAID |
Information Technology |
$8 |
1H FY26 Presentation
|
27 Feb 2026 8:14AM |
$0.026 |
$0.025 |
fallen by
3.85%
|
|
DXN - Price-sensitive ASX Announcement
Full Release
Key Points
- 1H FY26 revenues impacted by project delays but expected to strengthen.
- DXN's focus is on modular data centers, data center operations, and DCaaS.
- Strategic MOU with Super Sistem Indonesia to enter Southeast Asia market.
- FY26 backlog of $14.5 million, with 65% expected in 2H FY26.
- 80 projects identified in the pipeline as of January 2026.
- DXN's end-to-end business model leverages high-growth infrastructure sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TPG Telecom Limited (TPG) ORDINARY FULLY PAID |
Communication Services |
$8,480 |
Appendix 4E and 2025 Annual Report
|
27 Feb 2026 8:14AM |
$4.050 |
$4.320 |
risen by
6.67%
|
|
TPG - Price-sensitive ASX Announcement
Full Release
Key Points
- TPG Telecom's strategic initiatives led to a transformative year with increased national mobile coverage.
- The company executed a regional mobile network sharing arrangement and sold fibre network assets.
- TPG achieved a $3 billion capital return and reduced debt by $2.7 billion.
- Revenue from continuing operations reached $5,041 million with significant profit after tax from discontinued operations at $409 million.
- Declared a 30% franked final dividend of 9.0 cents per share.
- Focused on sustainability and strategic risk management.
- The annual report and Appendix 4E are audited by PricewaterhouseCoopers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,776 |
Update - Notification of buy-back - MGH
|
27 Feb 2026 8:14AM |
$4.690 |
$4.915 |
risen by
4.80%
|
|
| DXN Limited (DXN) ORDINARY FULLY PAID |
Information Technology |
$8 |
Strong Backlog in 1HFY26 and Strategic Progress in APAC
|
27 Feb 2026 8:14AM |
$0.026 |
$0.025 |
fallen by
3.85%
|
|
DXN - Price-sensitive ASX Announcement
Full Release
Key Points
- DXN Limited announced half-year results ending 31 December 2025 (1HFY26).
- Revenue decreased by 65% to $2.7 million due to project deferrals.
- Modular backlog increased to $10.1 million, total backlog at $14.5 million.
- Signed an MOU with Super Sistem Indonesia for a joint venture in Indonesia.
- Joint venture aims to establish localized manufacturing in Jakarta.
- First recurring revenue from Data Centre as a Service (DCaaS) was received.
- Focus on Asia-Pacific expansion with 80 identified projects in the pipeline.
- Targeting revenue growth in 2HFY26 as backlog converts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DXN Limited (DXN) ORDINARY FULLY PAID |
Information Technology |
$8 |
Half Yearly Report and Accounts
|
27 Feb 2026 8:14AM |
$0.026 |
$0.025 |
fallen by
3.85%
|
|
DXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Total comprehensive loss of $3,471,742 for the half-year.
- Significant decrease in revenue from external customers.
- High expenses in administration, employee benefits, and finance costs.
- Total assets of $12,964,617 and liabilities of $10,914,197.
- No dividends declared or recommended during the period.
- Expansion of operations with a new subsidiary in Singapore.
- Auditor's independence declaration includes a material uncertainty related to going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$385 |
Update - Notification of buy-back - ACL
|
27 Feb 2026 8:14AM |
$2.210 |
$2.050 |
fallen by
7.24%
|
|
| Spheria Emerging Companies Limited (SEC) ORDINARY FULLY PAID |
Financials |
$140 |
Net Tangible Asset Backing
|
27 Feb 2026 8:14AM |
$2.700 |
$2.340 |
fallen by
13.33%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$11 |
Change in substantial holding
|
27 Feb 2026 8:13AM |
$0.029 |
$0.033 |
risen by
13.79%
|
|
| SomnoMed Limited (SOM) ORDINARY FULLY PAID |
Health Care |
$126 |
Investor presentation
|
27 Feb 2026 8:13AM |
$0.660 |
$0.575 |
fallen by
12.88%
|
|
SOM - Price-sensitive ASX Announcement
Full Release
Key Points
- SomnoMed Limited reported a 13% increase in revenue for the first half of the fiscal year 2026, totaling $60.7 million.
- The company's EBITDA increased by 35% year-on-year, reaching $7.8 million, with an improved margin of 13%.
- SomnoMed is the global leader in oral appliance therapy for sleep apnea and is focusing on the expansion of its manufacturing capabilities.
- The company has developed Rest Assure®, an FDA-cleared oral device with built-in compliance monitoring, and is exploring options for accelerated commercialization.
- SomnoMed aims for sustainable growth and innovation, with plans for further investment in manufacturing site expansion and the development of new products.
- The company reported positive operating cash flow before and after leases of $4.1 million and $2.5 million respectively.
- SomnoMed has strengthened its leadership team with key appointments to support its growth strategy.
- The company is forecasting FY26 revenue between $119 million and $126 million and EBITDA between $10 million and $12 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Marimaca Copper Corp. (MC2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$1,228 |
Notification regarding unquoted securities - MC2
|
27 Feb 2026 8:13AM |
$10.450 |
$9.180 |
fallen by
12.15%
|
|
| Auric Mining Limited (AWJ) ORDINARY FULLY PAID |
Materials |
$61 |
Outstanding 2026 Gold Outturns at Munda
|
27 Feb 2026 8:13AM |
$0.275 |
$0.325 |
risen by
18.18%
|
|
AWJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Gold production and revenue exceeded budget expectations.
- Campaign Two at Munda produced 4,819 ounces of gold.
- Auric's metal account holds 3,272 ounces of gold at ABC Refinery.
- Cash, bullion, and investments total A$34 million for Auric.
- Processing was completed on 18 February 2026 at Lakewood Mill.
- Munda Main Pit is confirmed as a major economic resource.
- Auric aims to expand production and become a sustainable gold producer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SomnoMed Limited (SOM) ORDINARY FULLY PAID |
Health Care |
$126 |
Half year results announcement FY26
|
27 Feb 2026 8:12AM |
$0.660 |
$0.575 |
fallen by
12.88%
|
|
SOM - Price-sensitive ASX Announcement
Full Release
Key Points
- Record 1H FY26 revenue of $60.7 million, up 13% from 1H FY25.
- Europe and North America are major revenue contributors, with 54% and 40% respectively.
- EBITDA increased to $7.8 million, up 35% from the prior year.
- Significant manufacturing investments resulted in a 20% capacity increase.
- Reaffirmed FY26 guidance: revenue of $119m-$126m and EBITDA of $10m-$12m.
- Key senior leadership appointments included a new Chief Marketing Officer and Chief Transformation Officer.
- Focused on sustainable growth and leadership in oral appliance therapy for sleep disorders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HomeCo Daily Needs REIT (HDN) ORDINARY UNITS FULLY PAID |
Real Estate |
$2,575 |
Change in substantial holding
|
27 Feb 2026 8:12AM |
$1.300 |
$1.233 |
fallen by
5.19%
|
|
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$911 |
Change in substantial holding
|
27 Feb 2026 8:12AM |
$3.540 |
$3.515 |
fallen by
0.71%
|
|
| SomnoMed Limited (SOM) ORDINARY FULLY PAID |
Health Care |
$126 |
Half Yearly Report and Accounts
|
27 Feb 2026 8:12AM |
$0.660 |
$0.575 |
fallen by
12.88%
|
|
SOM - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax of $792,000, up from a loss of $106,000.
- Revenue increased by 13.1% to $60,717,000.
- No dividends declared for the half-year.
- Total assets reported at $79,899,000 and total equity at $50,036,000.
- Focus on producing and selling devices for sleep-related disorders.
- No significant changes in state of affairs or post-reporting events affecting operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gumtree Australia Markets Limited (GUM) ORDINARY FULLY PAID |
Communication Services |
$40 |
Investor Presentation - Half Yearly Results
|
27 Feb 2026 8:12AM |
$0.115 |
$0.125 |
risen by
8.70%
|
|
GUM - Price-sensitive ASX Announcement
Full Release
Key Points
- Gumtree Group, including Carsguide and Autotrader, expanded user reach in Australia.
- H1 FY26 total revenue was $35.2 million, down 7% from the previous year.
- EBITDA increased by 23% to $3.9 million due to cost savings.
- Gumtree Pay adoption grew with enhanced security features.
- User experience improvements led to higher ratings on app stores.
- Strategic partnerships increased total online audience to 6.7 million.
- Cost savings were achieved through streamlining head office operations.
- Focus on key verticals: Cars, Pets, Jobs, and Real Estate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gumtree Australia Markets Limited (GUM) ORDINARY FULLY PAID |
Communication Services |
$40 |
Half-Year Financial Results
|
27 Feb 2026 8:12AM |
$0.115 |
$0.125 |
risen by
8.70%
|
|
GUM - Price-sensitive ASX Announcement
Full Release
Key Points
- Gumtree reported H1 FY26 financial results with revenue of $35.2 million, a 7% decline.
- EBITDA increased by 23% to $3.9 million, and net profit before tax was $1.4 million.
- Operating cash flow reached $3.4 million, with a debt repayment of $2.2 million.
- Strategic advances included the growth of Gumtree Pay, a partnership with ACM, and user experience enhancements.
- Future strategies involve expanding Motors, adding transactional features, and further cost reduction.
- The company received an acquisition proposal but did not proceed due to lack of shareholder support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,609 |
Update - Notification of buy-back - DNL
|
27 Feb 2026 8:12AM |
$3.350 |
$3.195 |
fallen by
4.63%
|
|
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$104 |
Appendix 4D and Half Year Report
|
27 Feb 2026 8:11AM |
$0.270 |
$0.230 |
fallen by
14.81%
|
|
PAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of A$23,244,389 for the half-year ended 31 December 2025.
- Continued investment in Phase 3 clinical trial for knee osteoarthritis.
- Focus on global Phase 3 PARA_OA_012 trial interim analysis by mid-2026.
- Utilization of US$27 million convertible note facility for funding.
- Emphasis on regulatory engagement, scientific validation, and commercial readiness.
- Reviewed financial statements with no significant changes in affairs.
- Directors confident in Paradigm's path towards regulatory and commercial success.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
